Real-world evidence provides a description of patient characteristics and treatment patterns that are different from those reported by randomized clinical trials. Costs for the INHS are mainly driven by hospitalizations, which are often due to non-cardiovascular reasons.
Aldo Maggioni, Giulia Ronconi, Letizia Dondi, Letizia Dondi, Silvia Calabria, I Dell Anno, Carlo Piccinni, Antonella Pedrini, I Esposito, A Addesi, N. Martini
Discussion(0)
No comments yet. Be the first to comment.